Why the study?
Does carvedilol inhibit angiogenesis in a human umbilical vascular endothelial cell model?
Does carvedilol inhibit angiogenesis in a human umbilical vascular endothelial cell model?
Carvedilol exerts anti-angiogenic effects in vitro by inhibiting the VEGF-induced Src-ERK signaling pathway, suggesting a potential mechanism for attenuating liver cirrhosis.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for carvedilol in cirrhosis via anti-angiogenesis; clinical translation untested.
Qian Ding (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: